⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for salivary gland squamous cell carcinoma

Every month we try and update this database with for salivary gland squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00639769
Head and Neck C...
cisplatin
irinotecan hydr...
18 Years - Vanderbilt-Ingram Cancer Center
Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerNCT00040807
Head and Neck C...
docetaxel
irinotecan hydr...
18 Years - 120 YearsEastern Cooperative Oncology Group
Title XELOX FOR SALIVARY GLAND CANCERSNCT00101075
Head and Neck C...
Capecitabine
Oxaliplatin
18 Years - Dana-Farber Cancer Institute
Immunotoxin Therapy in Treating Patients With Advanced Solid TumorsNCT00066651
Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI)
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerNCT00006107
Head and Neck C...
Taxotere
Surgery
radiation thera...
18 Years - Dana-Farber Cancer Institute
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00020189
Head and Neck C...
Thromboembolism
acetylsalicylic...
alvocidib
clopidogrel bis...
18 Years - National Cancer Institute (NCI)
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00507767
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Germline Mutations in Patients With Head and Neck Cancer and a Family History of CancerNCT00482872
Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 YearsVanderbilt University Medical Center
S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00096512
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
sorafenib tosyl...
laboratory biom...
18 Years - National Cancer Institute (NCI)
DNA Analysis of Tissue Samples From Patients With Head and Neck CancerNCT00898664
Head and Neck C...
cytogenetic ana...
gene expression...
mutation analys...
polymerase chai...
immunohistochem...
laboratory biom...
18 Years - Vanderbilt-Ingram Cancer Center
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver MetastasesNCT00062348
Colorectal Canc...
Head and Neck C...
Metastatic Canc...
boronophenylala...
sodium borocapt...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerNCT00049140
Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckNCT02035527
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
sorafenib tosyl...
cisplatin
docetaxel
Correlative Stu...
18 Years - Ohio State University Comprehensive Cancer Center
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerNCT00897793
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
venipuncture
radiation thera...
18 Years - Vanderbilt-Ingram Cancer Center
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNCT00588770
Neck Squamous C...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Neck ...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Saliv...
Recurrent Sinon...
Salivary Gland ...
Stage IV Hypoph...
Stage IV Major ...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Major...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVA Sinon...
Stage IVB Laryn...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Major...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVB Sinon...
Stage IVC Laryn...
Stage IVC Laryn...
Stage IVC Lip a...
Stage IVC Major...
Stage IVC Oral ...
Stage IVC Oroph...
Stage IVC Sinon...
Tongue Carcinom...
Bevacizumab
Carboplatin
Cisplatin
Docetaxel
Fluorouracil
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerNCT00049140
Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck CancerNCT00898742
Head and Neck C...
DNA and tissue ...
reverse transcr...
mass spectromet...
- Vanderbilt-Ingram Cancer Center
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck CancerNCT00003251
Drug/Agent Toxi...
Head and Neck C...
Radiation Toxic...
amifostine trih...
cisplatin
paclitaxel
radiation thera...
18 Years - National Cancer Institute (NCI)
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckNCT00079053
Head and Neck C...
erlotinib hydro...
adjuvant therap...
18 Years - 120 YearsCanadian Cancer Trials Group
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryNCT00738868
Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI)
S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck CancerNCT00337129
Head and Neck C...
eribulin mesyla...
18 Years - National Cancer Institute (NCI)
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00507767
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck CancerNCT00084435
Head and Neck C...
cisplatin
docetaxel
radiation thera...
18 Years - SWOG Cancer Research Network
Radiation Therapy in Treating Patients With Head and Neck CancerNCT00021125
Head and Neck C...
Non-melanomatou...
adjuvant therap...
radiation thera...
- National Cancer Institute (NCI)
Trastuzumab in Treating Patients With Advanced Salivary Gland CancerNCT00004163
Head and Neck C...
Trastuzumab
18 Years - Dana-Farber Cancer Institute
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation TherapyNCT00898430
Head and Neck C...
DNA Microarray ...
MALDI-TOF mass ...
DNA microarray ...
- Vanderbilt-Ingram Cancer Center
Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell CancerNCT00896675
Head and Neck C...
proteomic profi...
proteomic profi...
- Vanderbilt-Ingram Cancer Center
Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck CancerNCT00899821
Head and Neck C...
aldesleukin
recombinant int...
sargramostim
immunologic tec...
biopsy
20 Years - 80 YearsNYU Langone Health
Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00639769
Head and Neck C...
cisplatin
irinotecan hydr...
18 Years - Vanderbilt-Ingram Cancer Center
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyNCT01156142
Head and Neck C...
Mucositis
Oral Complicati...
Pain
doxepin hydroch...
placebo
18 Years - Alliance for Clinical Trials in Oncology
Title XELOX FOR SALIVARY GLAND CANCERSNCT00101075
Head and Neck C...
Capecitabine
Oxaliplatin
18 Years - Dana-Farber Cancer Institute
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryNCT00738868
Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI)
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerNCT01313390
Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.NCT01469429
Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center
Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck CancerNCT00114283
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
lapatinib ditos...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Validation of a Screening Tool in Geriatric OncologyNCT00963911
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Lymphoma
Prostate Cancer
Geriatric scree...
Multidimensiona...
70 Years - 120 YearsInstitut Bergonié
Trastuzumab in Treating Patients With Advanced Salivary Gland CancerNCT00004163
Head and Neck C...
Trastuzumab
18 Years - Dana-Farber Cancer Institute
Germline Mutations in Patients With Head and Neck Cancer and a Family History of CancerNCT00482872
Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 YearsVanderbilt University Medical Center
Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent CetuximabNCT00939627
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
cetuximab
placebo
sorafenib tosyl...
laboratory biom...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell CancerNCT00896675
Head and Neck C...
proteomic profi...
proteomic profi...
- Vanderbilt-Ingram Cancer Center
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerNCT02245100
Metastatic Squa...
Salivary Gland ...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
Cytology specim...
Laboratory biom...
18 Years - Thomas Jefferson University
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckNCT00906360
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
sunitinib malat...
pharmacological...
3-dimensional c...
cetuximab
18 Years - National Cancer Institute (NCI)
Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and NeckNCT00081211
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
PV701
18 Years - National Cancer Institute (NCI)
Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During SurgeryNCT00003744
Head and Neck C...
gemcitabine
18 Years - Dana-Farber Cancer Institute
Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapyNCT00559156
Head and Neck C...
arginine/omega-...
cisplatin
adjuvant therap...
radiation thera...
18 Years - National Cancer Institute (NCI)
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNCT00588770
Neck Squamous C...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Neck ...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Saliv...
Recurrent Sinon...
Salivary Gland ...
Stage IV Hypoph...
Stage IV Major ...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Major...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVA Sinon...
Stage IVB Laryn...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Major...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVB Sinon...
Stage IVC Laryn...
Stage IVC Laryn...
Stage IVC Lip a...
Stage IVC Major...
Stage IVC Oral ...
Stage IVC Oroph...
Stage IVC Sinon...
Tongue Carcinom...
Bevacizumab
Carboplatin
Cisplatin
Docetaxel
Fluorouracil
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck CancerNCT00084435
Head and Neck C...
cisplatin
docetaxel
radiation thera...
18 Years - SWOG Cancer Research Network
Immunotoxin Therapy in Treating Patients With Advanced CancerNCT00006981
Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI)
Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck CancerNCT00003592
Head and Neck C...
methotrexate
paclitaxel
18 Years - 120 YearsEastern Cooperative Oncology Group
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerNCT01313390
Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London
Family Quality of Life Among Families With a Member Who is a Cancer PatientNCT00544336
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
Solid Tumor
questionnaire a...
survey administ...
quality-of-life...
21 Years - Vanderbilt-Ingram Cancer Center
Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell CancerNCT00896675
Head and Neck C...
proteomic profi...
proteomic profi...
- Vanderbilt-Ingram Cancer Center
Title XELOX FOR SALIVARY GLAND CANCERSNCT00101075
Head and Neck C...
Capecitabine
Oxaliplatin
18 Years - Dana-Farber Cancer Institute
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00507767
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerNCT00098631
Metastatic Squa...
Recurrent Metas...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Untreated Metas...
lapatinib ditos...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck CancerNCT00055770
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
erlotinib hydro...
docetaxel
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Immunotoxin Therapy in Treating Patients With Advanced CancerNCT00006981
Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI)
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryNCT00738868
Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI)
Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckNCT00033618
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
ixabepilone
laboratory biom...
18 Years - National Cancer Institute (NCI)
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionNCT01249443
HIV Infection
Recurrent Anal ...
Recurrent Breas...
Recurrent Esoph...
Recurrent Gastr...
Recurrent Metas...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Anal C...
Stage IV Breast...
Stage IV Esopha...
Stage IV Gastri...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
vorinostat
diagnostic labo...
pharmacological...
carboplatin
paclitaxel
18 Years - AIDS Malignancy Consortium
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00055913
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
bevacizumab
erlotinib hydro...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck CancerNCT00003592
Head and Neck C...
methotrexate
paclitaxel
18 Years - 120 YearsEastern Cooperative Oncology Group
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous TherapyNCT01256385
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Metas...
Recurrent Nasal...
Recurrent Nasop...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Saliv...
Salivary Gland ...
Squamous Cell C...
Stage IV Hypoph...
Stage IV Nasoph...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Major...
Stage IVA Nasal...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVB Laryn...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Major...
Stage IVB Nasal...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVC Laryn...
Stage IVC Laryn...
Stage IVC Lip a...
Stage IVC Major...
Stage IVC Nasal...
Stage IVC Oral ...
Stage IVC Oroph...
Tongue Carcinom...
Cetuximab
Laboratory Biom...
Temsirolimus
18 Years - National Cancer Institute (NCI)
Trastuzumab in Treating Patients With Advanced Salivary Gland CancerNCT00004163
Head and Neck C...
Trastuzumab
18 Years - Dana-Farber Cancer Institute
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.NCT01469429
Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & DysphagiaNCT00503776
Dysphagia
Head and Neck C...
Mucositis
Xerostomia
exercise interv...
amifostine trih...
therapeutic die...
21 Years - Vanderbilt-Ingram Cancer Center
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerNCT01316757
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
cetuximab
paclitaxel
carboplatin
erlotinib hydro...
laboratory biom...
18 Years - Fox Chase Cancer Center
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and PaclitaxelNCT00003569
Head and Neck C...
Lung Cancer
Neurotoxicity
Ovarian Cancer
cisplatin
dimesna
paclitaxel
18 Years - Roswell Park Cancer Institute
Radiation Therapy in Treating Patients With Head and Neck CancerNCT00021125
Head and Neck C...
Non-melanomatou...
adjuvant therap...
radiation thera...
- National Cancer Institute (NCI)
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerNCT00049140
Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University
S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck CancerNCT00337129
Head and Neck C...
eribulin mesyla...
18 Years - National Cancer Institute (NCI)
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerNCT01847326
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Tongue Cancer
carboplatin
paclitaxel albu...
fluorouracil
hydroxyurea
therapeutic con...
radiation thera...
hyperfractionat...
laboratory biom...
18 Years - University of Chicago
Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerNCT00024089
Head and Neck C...
gefitinib
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00020189
Head and Neck C...
Thromboembolism
acetylsalicylic...
alvocidib
clopidogrel bis...
18 Years - National Cancer Institute (NCI)
Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck CancerNCT00022217
Head and Neck C...
carboplatin
cisplatin-e the...
paclitaxel
18 Years - National Cancer Institute (NCI)
Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck CancerNCT00055770
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
erlotinib hydro...
docetaxel
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckNCT01334177
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
TLR8 agonist VT...
cetuximab
laboratory biom...
pharmacogenomic...
18 Years - University of Washington
Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck CancerNCT00003264
Head and Neck C...
cisplatin
gemcitabine hyd...
18 Years - Fox Chase Cancer Center
Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerNCT00024089
Head and Neck C...
gefitinib
18 Years - National Cancer Institute (NCI)
Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerNCT00058006
Head and Neck C...
Lung Cancer
celecoxib
adjuvant therap...
18 Years - Northwestern University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: